Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF COMPLEX OF CYSTEINE PROTEASE INHIBITOR AND CATHEPSIN AS TUMOR DIAGNOSTIC MARKER
Document Type and Number:
WIPO Patent Application WO/2022/083603
Kind Code:
A1
Abstract:
The present application relates to the use of a complex of a cysteine protease inhibitor and cathepsin as a tumor diagnostic marker, and a kit for tumor diagnosis, auxiliary diagnosis or prognosis analysis.

Inventors:
WANG LIJUN (CN)
SUN YULONG (CN)
YANG YAYUN (CN)
WANG TAO (CN)
Application Number:
PCT/CN2021/124817
Publication Date:
April 28, 2022
Filing Date:
October 20, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI LIANGRUN BIOMEDICINE TECH CO LTD (CN)
International Classes:
G01N33/574; G01N33/573
Foreign References:
CN112379093A2021-02-19
CN112379094A2021-02-19
CN112014578A2020-12-01
CN112379097A2021-02-19
CN107367615A2017-11-21
Other References:
ZORE I, ET AL.: "CATHEPSIN B/CYSTATIN C COMPLEX LEVELS IN SERA FROM PATIENTS WITH LUNG AND COLORECTAL CANCER", BIOLOGICAL CHEMISTRY, WALTER DE GRUYTER GMBH & CO., BERLIN, DE, vol. 382, no. 05, 1 May 2001 (2001-05-01), BERLIN, DE , pages 805 - 810, XP001107112, ISSN: 1431-6730, DOI: 10.1515/BC.2001.097
KOS J ET AL: "Cysteine proteinases and their inhibitors in extracellular fluids: Markers for diagnosis and prognosis in cancer.", INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS., WICHTIG EDITORE, MILAN., IT, vol. 15, no. 1, 1 January 2000 (2000-01-01), IT , pages 84 - 89, XP002220071, ISSN: 0393-6155
Attorney, Agent or Firm:
ADVANCE CHINA IP LAW OFFICE (CN)
Download PDF: